Coeliac disease
K Lindfors, C Ciacci, K Kurppa, KEA Lundin… - Nature reviews Disease …, 2019 - nature.com
Coeliac disease is an immune-mediated enteropathy against dietary gluten present in wheat,
rye and barley and is one of the most common lifelong food-related disorders worldwide. …
rye and barley and is one of the most common lifelong food-related disorders worldwide. …
[HTML][HTML] Extraintestinal manifestations of celiac disease: early detection for better long-term outcomes
P Laurikka, S Nurminen, L Kivelä, K Kurppa - Nutrients, 2018 - mdpi.com
Population-based screening studies have shown celiac disease to be one of the most
common chronic gastrointestinal diseases. Nevertheless, because of the diverse clinical …
common chronic gastrointestinal diseases. Nevertheless, because of the diverse clinical …
Multiple common variants for celiac disease influencing immune gene expression
…, D Kelleher, I Korponay-Szabo, K Kurppa… - Nature …, 2010 - nature.com
We performed a second-generation genome-wide association study of 4,533 individuals with
celiac disease (cases) and 10,750 control subjects. We genotyped 113 selected SNPs with …
celiac disease (cases) and 10,750 control subjects. We genotyped 113 selected SNPs with …
European society paediatric gastroenterology, hepatology and nutrition guidelines for diagnosing coeliac disease 2020
…, S Koletzko, I Korponay-Szabó, K Kurppa… - Journal of pediatric …, 2020 - journals.lww.com
Objectives: The ESPGHAN 2012 coeliac disease (CD) diagnostic guidelines aimed to guide
physicians in accurately diagnosing CD and permit omission of duodenal biopsies in …
physicians in accurately diagnosing CD and permit omission of duodenal biopsies in …
Celiac disease and health-related quality of life
K Kurppa, P Collin, M Mäki… - Expert review of …, 2011 - Taylor & Francis
Celiac disease is a particularly common life-long disorder with a prevalence of approximately
1–2% in Western populations. In recent years the health-related quality of life has become …
1–2% in Western populations. In recent years the health-related quality of life has become …
Diagnosing mild enteropathy celiac disease: a randomized, controlled clinical study
K Kurppa, P Collin, M Viljamaa, K Haimila… - Gastroenterology, 2009 - Elsevier
… iron level (reference values, 50–190 μg/dL), red blood cell folate level (E-folate) (reference
values, 200–700 nmol/L), and serum vitamin B 12 level (reference values, 150–740 pmol/K). …
values, 200–700 nmol/L), and serum vitamin B 12 level (reference values, 150–740 pmol/K). …
[PDF][PDF] Treatment-induced tumor dormancy through YAP-mediated transcriptional reprogramming of the apoptotic pathway
Eradicating tumor dormancy that develops following epidermal growth factor receptor (EGFR)
tyrosine kinase inhibitor (TKI) treatment of EGFR-mutant non-small cell lung cancer, is an …
tyrosine kinase inhibitor (TKI) treatment of EGFR-mutant non-small cell lung cancer, is an …
High frequency of BRAF V600E mutations in ameloblastoma
KJ Kurppa, J Catón, PR Morgan… - The Journal of …, 2014 - Wiley Online Library
… Kari J Kurppa … Kari J Kurppa … line; AR performed BRAF V600E immunohistochemistry; KK
conducted all the remaining experimental work; and KK, KE and KH prepared the manuscript. …
conducted all the remaining experimental work; and KK, KE and KH prepared the manuscript. …
Accuracy in diagnosis of celiac disease without biopsies in clinical practice
…, H Garnier-Lengliné, G Castillejo, K Kurppa… - Gastroenterology, 2017 - Elsevier
Background & Aims The guidelines of the European Society of Pediatric Gastroenterology,
Hepatology, and Nutrition allow for diagnosis of celiac disease without biopsies in children …
Hepatology, and Nutrition allow for diagnosis of celiac disease without biopsies in children …
An allosteric inhibitor against the therapy-resistant mutant forms of EGFR in non-small cell lung cancer
…, PC Gokhale, Y Kobayashi, K Wahid, KJ Kurppa… - Nature cancer, 2022 - nature.com
Epidermal growth factor receptor (EGFR) therapy using small-molecule tyrosine kinase
inhibitors (TKIs) is initially efficacious in patients with EGFR-mutant lung cancer, although drug …
inhibitors (TKIs) is initially efficacious in patients with EGFR-mutant lung cancer, although drug …